Cargando…
Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
OBJECTIVES: Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Disease Control and Prevention Agency
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721267/ https://www.ncbi.nlm.nih.gov/pubmed/34965687 http://dx.doi.org/10.24171/j.phrp.2021.0146 |
_version_ | 1784625301834170368 |
---|---|
author | Oh, Eun Ju Yuk, Young Sam Kim, Jae Kyung |
author_facet | Oh, Eun Ju Yuk, Young Sam Kim, Jae Kyung |
author_sort | Oh, Eun Ju |
collection | PubMed |
description | OBJECTIVES: Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide information that could be used to reduce the incidence of genital herpes caused by HSV-1 and HSV-2. METHODS: From September 2018 to December 2020, 59,381 specimens were collected from outpatients across primary and secondary hospitals in Korea who requested U2Bio (Korea) to conduct molecular biological testing of their samples for sexually transmitted infections. In this study, the positivity rates of HSV-1 and HSV-2 were analyzed according to age, sex, and specimen type. RESULTS: In the age-specific analysis of HSV-1, the highest positivity rate (0.58%) was observed in patients under 19 years of age, whereas the lowest positivity rate (0.08%) was observed in patients aged over 70 years. In the age-specific analysis of HSV-2, the highest positivity rate (2.53%) was likewise observed in patients under 19 years of age. CONCLUSION: Our study identified differences in the infection rates of HSV-1 and HSV-2 depending on patients’ sex and age. These differences will be useful for improving disease prevention and control measures for HSV-1 and HSV-2. |
format | Online Article Text |
id | pubmed-8721267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Korea Disease Control and Prevention Agency |
record_format | MEDLINE/PubMed |
spelling | pubmed-87212672022-01-11 Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea Oh, Eun Ju Yuk, Young Sam Kim, Jae Kyung Osong Public Health Res Perspect Original Article OBJECTIVES: Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide information that could be used to reduce the incidence of genital herpes caused by HSV-1 and HSV-2. METHODS: From September 2018 to December 2020, 59,381 specimens were collected from outpatients across primary and secondary hospitals in Korea who requested U2Bio (Korea) to conduct molecular biological testing of their samples for sexually transmitted infections. In this study, the positivity rates of HSV-1 and HSV-2 were analyzed according to age, sex, and specimen type. RESULTS: In the age-specific analysis of HSV-1, the highest positivity rate (0.58%) was observed in patients under 19 years of age, whereas the lowest positivity rate (0.08%) was observed in patients aged over 70 years. In the age-specific analysis of HSV-2, the highest positivity rate (2.53%) was likewise observed in patients under 19 years of age. CONCLUSION: Our study identified differences in the infection rates of HSV-1 and HSV-2 depending on patients’ sex and age. These differences will be useful for improving disease prevention and control measures for HSV-1 and HSV-2. Korea Disease Control and Prevention Agency 2021-12 2021-12-02 /pmc/articles/PMC8721267/ /pubmed/34965687 http://dx.doi.org/10.24171/j.phrp.2021.0146 Text en © 2021 Korea Disease Control and Prevention Agency. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Original Article Oh, Eun Ju Yuk, Young Sam Kim, Jae Kyung Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea |
title | Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea |
title_full | Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea |
title_fullStr | Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea |
title_full_unstemmed | Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea |
title_short | Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea |
title_sort | laboratory investigations of herpes simplex virus-1 and -2 clinical samples in korea |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721267/ https://www.ncbi.nlm.nih.gov/pubmed/34965687 http://dx.doi.org/10.24171/j.phrp.2021.0146 |
work_keys_str_mv | AT oheunju laboratoryinvestigationsofherpessimplexvirus1and2clinicalsamplesinkorea AT yukyoungsam laboratoryinvestigationsofherpessimplexvirus1and2clinicalsamplesinkorea AT kimjaekyung laboratoryinvestigationsofherpessimplexvirus1and2clinicalsamplesinkorea |